Search

everythinglearnresearchcommunity

for

Search:↓

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Finasteride effectively treats baldness but may cause sexual side effects.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

No cure for female pattern hair loss, but various effective treatments exist.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

DHT, a testosterone byproduct, causes male pattern baldness.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Organotypic culture systems can grow skin tissues that mimic real skin functions and are useful for skin disease and hair growth research, but they don't fully replicate skin complexity.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Low prolactin in young women may increase heart and metabolism risks.